Aldeyra Therapeutics Earning Date (ALDX)

USA |NASDAQ |USD

ALDX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 9, 2022 Dec 2021 $-0.27 - $-0.30
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 9, 2022 Dec 2021 $0.00 - $0.00

Aldeyra Therapeutics's next earnings date is Wednesday, Mar 9, 2022 for the fiscal quarter ending Dec 2021.

ALDX Earnings Date & History Chart

ALDX Earnings & Revenue Forecast

ALDX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-0.27 $-0.34 $-0.18
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-1.08 $-1.20 $-0.94
Dec 2022 10 $-1.22 $-2.30 $0.20

ALDX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.27 $-0.26 $-0.26
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.08 $-1.05 $-1.00
Dec 2022 0 / 0 $-1.22 $-1.20 $-1.14

ALDX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $0.00 $0.00 $0.00
Dec 2022 8 $18.30M $0.00 $77.07M

ALDX Earnings Date & Revenue History

ALDX Earnings History

|
Show More
Show More

ALDX Revenue History

|
Show More
Show More

Aldeyra Therapeutics Next Earnings Date & Report

ALDX Next Earnings Date & Report Preview: Dec 2021 (FQ)

ALDX's next earnings date is Wednesday, Mar 9, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Aldeyra Therapeutics's next quarterly earnings is $-0.27, with a low EPS estimation of $-0.34, and a high estimation of $-0.18.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.27, the last 2 month trend is $-0.26, and the 3 month trend is $-0.26.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Aldeyra Therapeutics Previous Earnings Dates & Reports

ALDX Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Aldeyra Therapeutics's previous earnings date was Oct 28, 2021 for its fiscal quarter ended Sep 30, 2021.

ALDX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aldeyra Therapeutics's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

ALDX's earnings per share (EPS) was $-1.12, missing the consensus analysts forecast of $-1.09 by 2.75% , and higher than the previous year's EPS (Dec 2019) by -50.00%.

Revenues were $0.00.

The company reported a net income of $-37.55M.

Aldeyra Therapeutics reported a free cash flow of $-37.49M for its fiscal year, compared to $-44.99M a year ago.

The company ended the fiscal year with $15.33M in total debt, an increase of 3.88% compared to the previous year.